These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4261258)

  • 21. The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis.
    Mosesson MW; Finlayson JS; Galanakis DK
    J Biol Chem; 1973 Nov; 248(22):7913-29. PubMed ID: 4127218
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydroxyproline content of plasma proteins.
    Bańkowski E; Galasiński W; Rogowski W; Rzeczycki W
    Biochim Biophys Acta; 1972 Jul; 271(2):332-8. PubMed ID: 4114786
    [No Abstract]   [Full Text] [Related]  

  • 23. Preparation of fibrin monomers from human fibrinogen in urea, using soluble or insolubilized thrombin.
    Brosstad F; Godal HC; Kierulf P
    Haemostasis; 1977; 6(4):225-35. PubMed ID: 914081
    [No Abstract]   [Full Text] [Related]  

  • 24. Subunit structure of fragment D from fibrinogen and cross-linked fibrin.
    Pizzo SV; Taylor LM; Schwartz ML; Hill RL; McKee PA
    J Biol Chem; 1973 Jul; 248(13):4584-90. PubMed ID: 4198060
    [No Abstract]   [Full Text] [Related]  

  • 25. [Zone-electrophoretic, chromatographic and spectrographic studies on fibrinogens of normal and cobalt treated rabbits].
    Krantz S; Fiedler H; Lober M
    Acta Biol Med Ger; 1970; 25(4):523-37. PubMed ID: 5518786
    [No Abstract]   [Full Text] [Related]  

  • 26. Human fibrinogen heterogeneities. 3. Identification of chain variants.
    Mosesson MW; Finlayson JS; Umfleet RA
    J Biol Chem; 1972 Aug; 247(16):5223-7. PubMed ID: 5057464
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrinogen St. Louis: a new inherited fibrinogen variant, coincidentally associated with hemophilia A.
    Sherman LA; Gaston LW; Kaplan ME; Spivack AR
    J Clin Invest; 1972 Mar; 51(3):590-7. PubMed ID: 4622105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen derivatives. A laboratory and clinical study.
    Vermylen J
    Verh K Vlaam Acad Geneeskd Belg; 1972; 34(2):125-208. PubMed ID: 4278099
    [No Abstract]   [Full Text] [Related]  

  • 29. Isolation and some properties of fibrinogen from human blood platelets.
    Ganguly P
    J Biol Chem; 1972 Mar; 247(6):1809-16. PubMed ID: 4258978
    [No Abstract]   [Full Text] [Related]  

  • 30. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
    Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
    Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of highly ordered polymers from fibrinogen and fibrin degradation products.
    Niewiarowski S; Stewart GJ; Marder VJ
    Biochim Biophys Acta; 1970 Nov; 221(2):326-41. PubMed ID: 4249928
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticoagulants produced by thrombin from fibrin, the effect on blood coagulation, some physical characteristics.
    Muirhead CR; Triantaphyllopoulos DC
    Thromb Diath Haemorrh; 1971 Oct; 26(2):211-23. PubMed ID: 5316291
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence for aggregation of fibrin fragments D and E in soluble fibrin complex formation.
    Chang ML; Latallo ZS; Bang NU; Mattler LE; Hansen MS
    Thromb Res; 1974 Dec; 5(6):719-34. PubMed ID: 4445994
    [No Abstract]   [Full Text] [Related]  

  • 34. The prolonged thrombin time of nephrotic syndrome.
    Abshire TC; Fink LK; Christian J; Hathaway WE
    J Pediatr Hematol Oncol; 1995 May; 17(2):156-62. PubMed ID: 7749766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and some properties of fibrin stabilizing factor.
    Takagi T; Konishi K
    Biochim Biophys Acta; 1972 Jul; 271(2):363-70. PubMed ID: 5065313
    [No Abstract]   [Full Text] [Related]  

  • 36. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of soluble fibrin complexes and some factors affecting their solubility.
    Wegrzynowicz Z; Kopeć M; Latallo ZS
    Scand J Haematol Suppl; 1971; 13():49-59. PubMed ID: 5290703
    [No Abstract]   [Full Text] [Related]  

  • 38. Neoantigenic expressions engendered by plasmin cleavage of fibrinogen.
    Plow EF; Hougie C; Edgington TS
    J Immunol; 1971 Nov; 107(5):1496-500. PubMed ID: 4107365
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and characterization of subunit polypeptides from apoproteins of rat serum lipoprotein.
    Koga S; Bolis L; Scanu AM
    Biochim Biophys Acta; 1971 May; 236(2):416-30. PubMed ID: 4998783
    [No Abstract]   [Full Text] [Related]  

  • 40. Formation of soluble fibrinogen-fibrin complex in liquid human plasma; reflexion of coagulation process in storage.
    Abe T; Kazama M; Tahara C; Miura Y; Yasuda J
    Jpn J Med Sci Biol; 1977 Apr; 30(2):91-9. PubMed ID: 916354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.